“Specific therapies with few side effects should be available to cancer patients faster than previously possible – that is the goal of our company.”

PD dr Barbara Mayer and PD Dr. Ilona Funke, the founders of Spherotec GmbH

• Identify promising active ingredients at an early stage
• Recognizing undesirable effects early on
• Optimizing the life cycle management of medicines
• Use animal experiments in a more targeted and economical manner